Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03789396 · ClinicalTrials.gov registry record
Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 572
- Enrollment target
NCT03789396: Completed study, sponsored by University of Colorado, Denver.
NCT03789396 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 572 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03789396 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 572 participants
- Enrollment target
Study Summary
The objective of this study is to conduct an observational pre/post study to evaluate the clinical impact oxygen guideline implementation on oxygen utilization and oxygenation in critically ill trauma patients.
Primary Outcome
Total percentage of patient-time hyperoxic and not on room air: total time spent by patients in a hyperoxic state while receiving supplemental oxygen, divided by total patient time on study
Interventions
- OTHER Targeted Normoxia (oxygen saturation 90-96%)
- OTHER Usual Care Oxygenation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 572 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2022-10-01 |
What the finished NCT03789396 record still lists
NCT03789396 is an observational study that tracks outcomes without assigning an intervention. The registered 572 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Targeted Normoxia (oxygen saturation 90-96%) is the first listed.
NCT03789396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03789396 about?
NCT03789396 is a clinical study titled "Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients". The objective of this study is to conduct an observational pre/post study to evaluate the clinical impact oxygen guideline implementation on oxygen utilization and oxygenation in critically ill trauma patients.
What is the current status of trial NCT03789396?
This trial is currently completed. The enrollment target is 572 participants. The study started on 2018-01-01. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT03789396?
The interventions under investigation include: Targeted Normoxia (oxygen saturation 90-96%) (OTHER), Usual Care Oxygenation (OTHER).
Who is sponsoring clinical trial NCT03789396?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131022 · 572 participants · Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- NCT06346392 · 572 participants · Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
- NCT06615050 · 572 participants · Phase 3
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- NCT07192055 · 572 participants · NA
Self-sampling to Optimize Anal Lesion Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI